IGFBP3 and non-small cell lung carcinoma: A study conducted on NSCLC cells that had developed resistance to cisplatin showed a decrease in the expression of IGFBP-3 and an increase in the activation of IGF-1R signaling, leading to the development of cisplatin resistance in NSCLC [109].